Mountain View
Being Patient
Anosognosia: What to Do When Someone Is Unaware They Have Dementia
Over 80 percent of people living with Alzheimer’s disease are unable to recognize their own cognitive decline, according to Cleveland Clinic. Anosognosia is the... The post Anosognosia: What to Do When Someone Is Unaware They Have Dementia appeared first on Being Patient.
VOICES: In Our Essay Series, Dementia Caregivers Tell All
When a family member is diagnosed with dementia, the people that step into the caregiving role are often those closest to them. Caregivers must... The post VOICES: In Our Essay Series, Dementia Caregivers Tell All appeared first on Being Patient.
Ask Teepa Anything: Your Dementia Caregiving Questions Answered
Positive Approach to Care founder and dementia care expert Teepa Snow returns to our Live Talks series for another session of “Ask Teepa Anything,”... The post Ask Teepa Anything: Your Dementia Caregiving Questions Answered appeared first on Being Patient.
Australia Is Latest Country to Say ‘No’ to Leqembi
Eisai and Biogen’s Alzheimer’s drug Leqembi (generic name lecanemab) was the first fully-FDA approved disease-modifying treatment for early-stage Alzheimer’s disease in United States history,... The post Australia Is Latest Country to Say ‘No’ to Leqembi appeared first on Being Patient.
For Years They Lived With Alzheimer’s. Then New Information Came to Light
What would you do if, after years of living with Alzheimer’s disease, you found out you were misdiagnosed? Retired neuroscience nurse practitioner Doreen Monks... The post For Years They Lived With Alzheimer’s. Then New Information Came to Light appeared first on Being Patient.
A Common Parasite Could One Day Deliver Drugs to the Brain
Parasites take an enormous toll on human and veterinary health. But researchers may have found a way for patients with brain disorders and a... The post A Common Parasite Could One Day Deliver Drugs to the Brain appeared first on Being Patient.
8/11 of the Doctors Who Advised on Kisunla Approval Had Conflicts of Interest
The new monoclonal anti-amyloid Alzheimer’s drugs are a constant source of controversy among doctors, insurers, and regulators worldwide. One of this buzzy new drug class,... The post 8/11 of the Doctors Who Advised on Kisunla Approval Had Conflicts of Interest appeared first on Being Patient.
STUDY: Science Behind Food Preferences, Cognition, and Brain Health
From the crispy crunch of fresh veggies to the creamy indulgence of decadent desserts, we all have different food preferences. Our palates develop uniquely,... The post STUDY: Science Behind Food Preferences, Cognition, and Brain Health appeared first on Being Patient.
After Cassava Fraud Indictment, Questioning the Ethics of Simufilam Trial
On September 26th, Cassava Sciences’ founder and former CEO Remi Barbier, as well as former vice president Lindsay Burns agreed to pay the Securities... The post After Cassava Fraud Indictment, Questioning the Ethics of Simufilam Trial appeared first on Being Patient.
STUDY: 1/5 Dementia Cases Come With Vision Impairment
It’s long been said that the eyes are the windows to the soul, but more and more research supports findings that the eyes are... The post STUDY: 1/5 Dementia Cases Come With Vision Impairment appeared first on Being Patient.
Dr. Barak Gaster: How to Pick Up on Early Signs of Alzheimer’s Disease
Receiving an Alzheimer’s diagnosis is often a long, complex process, with many individuals facing delayed diagnosis or even misdiagnosis for years. A key reason... The post Dr. Barak Gaster: How to Pick Up on Early Signs of Alzheimer’s Disease appeared first on Being Patient.
Biden Signs 2 New Laws to Protect and Expand ‘National Alzheimer’s Project’
“No president has entered the White House with as clear a focus on Alzheimer’s disease as Joe Biden,” Maria Shriver and George Vradenburg wrote... The post Biden Signs 2 New Laws to Protect and Expand ‘National Alzheimer’s Project’ appeared first on Being Patient.
FDA-Approved Zunveyl for Alzheimer’s Symptoms On the Way in 2025
While the world tracks the progress of disease-modifying Alzheimer’s anti-amyloids through the drug development and FDA approval pipeline, there are symptomatic treatments making their... The post FDA-Approved Zunveyl for Alzheimer’s Symptoms On the Way in 2025 appeared first on Being Patient.
VOICES: Our Latest Lessons From Dementia Caregivers
Being a caregiver to someone living with dementia is a role that many people take on with little or no prior experience with the... The post VOICES: Our Latest Lessons From Dementia Caregivers appeared first on Being Patient.
Are Alzheimer’s Blood Tests Living Up to the Hype?
Getting an accurate Alzheimer’s diagnosis can take years — and several visits to the doctor. After taking a medical history, neurological exam, and blood tests... The post Are Alzheimer’s Blood Tests Living Up to the Hype? appeared first on Being Patient.
What is Anosognosia and Why Does it Matter in Dementia Care?
Anosognosia is a neurological condition in which a person is unaware that they have a particular disease. For people living with Alzheimer’s disease and... The post What is Anosognosia and Why Does it Matter in Dementia Care? appeared first on Being Patient.
What Links Aging and Disease? Research Points to Metabolism
Aging is a biological process that no one can avoid. Ideally, growing old should be a time to relax and enjoy the fruits of... The post What Links Aging and Disease? Research Points to Metabolism appeared first on Being Patient.
Early Signs of Dementia: How Much Memory Loss Is ‘Normal’?
You’ve driven home from work along the same route for the past five years. But lately, you’ve been stopping at the same intersection, struggling... The post Early Signs of Dementia: How Much Memory Loss Is ‘Normal’? appeared first on Being Patient.
Being Patient
434+
Posts
217K+
Views
Being Patient is creating a new formula for the way people get information on the research of Alzheimer’s disease and brain health. Our objective is to provide an editorially independent site run by journalists where readers and viewers can stay abreast of the latest research, connect with the expert community and understand the disease from the patient and caregiver's perspective.
It’s essential to note our commitment to transparency:
Our Terms of Use acknowledge that our services may not always be error-free, and our Community Standards emphasize our discretion in enforcing policies. As a platform hosting over 100,000 pieces of content published daily, we cannot pre-vet content, but we strive to foster a dynamic environment for free expression and robust discourse through safety guardrails of human and AI moderation.